DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Oncternal Therapeutics Q4 EPS $(0.27) Down From $(0.21) YoY, Sales $737K Up From $477K YoY

Oncternal Therapeutics (NASDAQ:ONCT) reported quarterly losses of $(0.27) per share. This is a 28.57 percent decrease over losses of $(0.21) per share from the same period last year. The company reported $737 thousand

Benzinga · 03/16/2020 20:09

Oncternal Therapeutics (NASDAQ:ONCT) reported quarterly losses of $(0.27) per share. This is a 28.57 percent decrease over losses of $(0.21) per share from the same period last year. The company reported $737 thousand in sales this quarter. This is a 54.51 percent increase over sales of $477 thousand the same period last year.